Cargando…
Network dynamics-based cancer panel stratification for systemic prediction of anticancer drug response
Cancer is a complex disease involving multiple genomic alterations that disrupt the dynamic response of signaling networks. The heterogeneous nature of cancer, which results in highly variable drug response, is a major obstacle to developing effective cancer therapy. Previous studies of cancer thera...
Autores principales: | Choi, Minsoo, Shi, Jue, Zhu, Yanting, Yang, Ruizhen, Cho, Kwang-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5717260/ https://www.ncbi.nlm.nih.gov/pubmed/29208897 http://dx.doi.org/10.1038/s41467-017-02160-5 |
Ejemplares similares
-
Evaluating a therapeutic window for precision medicine by integrating genomic profiles and p53 network dynamics
por: Choi, Minsoo, et al.
Publicado: (2022) -
Cell type–dependent bimodal p53 activation engenders a dynamic mechanism of chemoresistance
por: Yang, Ruizhen, et al.
Publicado: (2018) -
Protein Tyrosine Kinase Panel As a Tool for Anticancer Drug Design
por: Rakitina, T.V., et al.
Publicado: (2009) -
An isogenic cell line panel for sequence-based screening of targeted anticancer drugs
por: Cook, Ashley L., et al.
Publicado: (2022) -
The co-regulation mechanism of transcription factors in the human gene regulatory network
por: Kim, Junil, et al.
Publicado: (2012)